Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

In a new blog series, researchers in the OxImmnuo Literature initiative select papers that cover topics in COVID-19 research that they think may be of interest to the wider public and summarise them for a more general audience

Stack of academic papers with text highlighted and a pen resting on top

The OxImmuno Literature initiative has collected together a team of around 100 researchers from the Medical Sciences Division of the University of Oxford to read, review and summarise recent COVID-19 research from all round the world in order to support the researchers working on COVID-19 here at the University of Oxford.

Research papers are peer reviewed, ie. read and checked by other scientists, before they are published in research journals. As COVID-19 is such a new phenomenon most of the research has not yet had time to be peer reviewed but, in order to help other scientists working on COVID-19, research is still made available as a pre-print for other researchers to read.

Our summaries of some of these pre-prints and papers can be read here. However, these are written for other researchers. We have selected a few papers that cover topics in COVID-19 research that we think may be of interest to the wider public and have summarised them for a more general audience and included more background information. These summaries, with links to the original research, can be found in this, our new blog.

The blogs are available on the Nuffield Department of Orthopaedics, Rheumatology & Musculoskeletal Sciences website

Similar stories

Latest data on immune response to COVID-19 reinforces need for vaccination, says Oxford-led study

A new study led by the University of Oxford has found that previous infection, whether symptomatic or asymptomatic, does not necessarily protect you long-term from COVID-19, particularly against new Variants of Concern.

First trimester placental scan - Artificial Intelligence in Health and Care Award

A first trimester 3D placental ultrasound scan which can predict fetal growth restriction and pre-eclampsia, could become part of a woman's routine care thanks to a new Artificial Intelligence in Health and Care Award.

Impaired antibody response to COVID-19 vaccination in patients with myeloid blood cancers

Oxford researchers have found that antibody responses to the first doses of COVID-19 vaccine in people with chronic myeloid blood cancers are not as strong as those among the general population.

Treating Needle Fears May Reduce COVID-19 Vaccine Hesitancy Rates by 10%

A new large-scale study shows that a quarter of the UK adult population screens positive for a potential injection phobia.

RECOVERY trial Regeneron’s monoclonal antibody combination reduces deaths for hospitalised COVID-19 patients

The Randomised Evaluation of COVID-19 Therapy (RECOVERY) trial has demonstrated that the investigational antibody combination developed by Regeneron reduces the risk of death when given to patients hospitalised with severe COVID-19 who have not mounted a natural antibody response of their own.

Major new study could help protect millions of people with type 2 diabetes from cardiovascular disease

A new study led by the Nuffield Department of Population Health at the University of Oxford will research whether a daily tablet could help protect the millions of people worldwide with type 2 diabetes from developing cardiovascular disease.